These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 7527761

  • 1. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM, Faulds D.
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [Abstract] [Full Text] [Related]

  • 2. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 3. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
    Langtry HD, Wilde MI.
    Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
    [Abstract] [Full Text] [Related]

  • 4. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ, Jarvis B.
    Drugs; 2001 Sep; 61(12):1801-33. PubMed ID: 11693467
    [Abstract] [Full Text] [Related]

  • 5. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA.
    Expert Opin Pharmacother; 2001 Oct; 2(10):1663-70. PubMed ID: 11825309
    [Abstract] [Full Text] [Related]

  • 6. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A, Wiseman L.
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [Abstract] [Full Text] [Related]

  • 7. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Mar; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 8. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
    Wilde MI, McTavish D.
    Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198
    [Abstract] [Full Text] [Related]

  • 9. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Jul; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 10. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [Abstract] [Full Text] [Related]

  • 11. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Oct; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 12. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD, Wilde MI.
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [Abstract] [Full Text] [Related]

  • 13. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP, Campoli-Richards DM.
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [Abstract] [Full Text] [Related]

  • 14. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 Jul; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 15. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 16. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM.
    Arch Intern Med; 2000 May 22; 160(10):1455-61. PubMed ID: 10826458
    [Abstract] [Full Text] [Related]

  • 17. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar 22; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 18. Effect of lansoprazole on peptic ulcers.
    Ohashi T, Sakata J, Haraguchi Y, Eto T.
    J Clin Gastroenterol; 1995 Mar 22; 20 Suppl 2():S83-5. PubMed ID: 7594350
    [Abstract] [Full Text] [Related]

  • 19. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA.
    Am J Health Syst Pharm; 1996 Jun 15; 53(12):1401-15. PubMed ID: 8781686
    [Abstract] [Full Text] [Related]

  • 20. Rapid healing of gastric ulcers with lansoprazole.
    Bardhan KD, Ahlberg J, Hislop WS, Lindholmer C, Long RG, Morgan AG, Sjostedt S, Smith PM, Stig R, Wormsley KG.
    Aliment Pharmacol Ther; 1994 Apr 15; 8(2):215-20. PubMed ID: 8038354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.